What are the causes and risk factors for developing Parkinson's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How Someone Gets Parkinson's Disease

Parkinson's disease develops through a combination of genetic susceptibility and environmental exposures, though in most cases (>95%) the exact cause remains unknown and is classified as "idiopathic." 1

The Underlying Disease Process

Parkinson's disease is fundamentally a synucleinopathy - a condition where abnormal deposits of alpha-synuclein protein form Lewy bodies in brain neurons 1. The disease begins years before symptoms appear:

  • Initial pathology starts in the medulla oblongata, pontine tegmentum, and olfactory system
  • Progressive spread eventually reaches the substantia nigra (the dopamine-producing region)
  • Symptoms emerge only after approximately 40-50% of dopaminergic neurons have already been lost - typically about 5 years after neuronal degeneration begins 1

This explains why by the time someone develops tremor, rigidity, or slowness of movement, substantial brain damage has already occurred.

Genetic Causes (Minority of Cases)

Less than 5% of Parkinson's cases are monogenic (caused by single gene mutations) 2:

Autosomal dominant forms:

  • SNCA, LRRK2, VPS35 genes

Autosomal recessive forms:

  • Parkin, PINK1, DJ-1 genes

For the remaining 95% of cases (idiopathic PD), 26 genetic risk loci have been identified, but these contribute small individual risks and don't directly "cause" the disease 2.

Environmental Risk Factors

The most robust evidence supports these exposures as genuine risk factors 3, 4:

Established risk factors:

  • Pesticide exposure - strongest environmental association
  • Heavy metals (particularly lead)
  • Air pollution
  • Traumatic brain injury
  • Organic solvent exposure

Medical conditions that increase risk:

  • Type 2 Diabetes
  • Hepatitis C infection
  • H. pylori infection
  • COVID-19 infection
  • Cardiovascular disease 3

Protective Factors (Paradoxically)

Important caveat: Some "protective" associations may actually represent reverse causation - meaning early Parkinson's pathology changes behavior years before diagnosis 3:

  • Tobacco use (likely reverse causation - prodromal PD reduces smoking tendency)
  • Coffee/caffeine consumption (possibly reverse causation)
  • Physical activity (genuine protective effect)
  • NSAID use
  • Certain medications (calcium channel blockers, statins, some α1-adrenergic antagonists) 3

Age and Sex as Risk Factors

  • Peak age of onset: 60-70 years 1
  • Annual incidence: 10-18 per 100,000 in the general population
  • Men are affected more commonly than women 4, 5

Clinical Implications for Risk Assessment

Who should consider genetic counseling:

  • Patients with positive family history
  • Early-onset disease (before age 50)
  • Atypical features suggesting monogenic forms 2

Common pitfall: Currently, disease prediction based on genetic or environmental factors is not possible for idiopathic Parkinson's disease 2. There are no validated prevention strategies or screening programs, though research into modifiable risk factors (physical activity, diabetes control, reducing pesticide exposure) shows promise 6, 3, 4.

The disease represents a multifactorial process where genetic susceptibility meets environmental triggers over decades, with the brain silently compensating until a critical threshold of neuronal loss is crossed.

References

Guideline

acr appropriateness criteria® movement disorders and neurodegenerative diseases.

Journal of the American College of Radiology, 2020

Research

Update: Protective and risk factors for Parkinson disease.

Parkinsonism & related disorders, 2024

Research

The epidemiology of Parkinson's disease.

Lancet (London, England), 2024

Research

Parkinson's disease: evidence for environmental risk factors.

Movement disorders : official journal of the Movement Disorder Society, 2013

Research

Prevention of Parkinson's Disease: From Risk Factors to Early Interventions.

CNS & neurological disorders drug targets, 2024

Related Questions

What is the recommended management for a Parkinson’s disease patient with predominant speech impairment and functional aphonia, drooling, mild upper‑limb tremor, no cogwheel rigidity, intact cognition, and poor response of speech symptoms to dopaminergic medication while maintaining a normal diet and fluid intake?
Do patients with Parkinson's disease experience autonomic dysfunction?
What are the early symptoms of Parkinson's disease?
What is the recommended treatment for increased neuropathic pain in a patient with Parkinson’s disease?
What medications can be used to treat tremor in a patient without a history of Parkinson's disease, including recommended agents and typical dosing regimens?
My relative, who has been off clonazepam 1 mg for two days, can she resume the 1 mg dose as soon as her prescription is filled?
Can I paste my Portuguese MRI report here to receive an English translation and summary of the findings?
In an 83-year-old man four days post‑operative from left hip fracture repair who is now disoriented, febrile, hypertonic, and has brisk reflexes without focal weakness, which is the most urgent next step: bedside swallow evaluation, serum total thyroxine level, non‑contrast head CT, or EEG?
What are the therapeutic uses, recommended dosage, safety considerations, and contraindications of taurine supplementation in adults?
For a 59-year-old man with hypertension and gastroesophageal reflux disease who has two weeks of daily chest pain related to eating, progressive dysphagia to solids and liquids, 10‑lb weight loss, and no fever, which is the most appropriate next diagnostic test: barium esophagram, CT scan, Helicobacter pylori testing, or upper endoscopy (esophagogastroduodenoscopy)?
In an HIV‑positive immunocompromised patient with MRI showing multiple ring‑enhancing necrotic lesions in the left basal ganglia, internal capsule, caudate nucleus, splenium of the corpus callosum, and left cerebellar vermis, and MR spectroscopy demonstrating a marked increase in choline, loss of N‑acetyl‑aspartate and no significant amino‑acid peaks, what is the appropriate empiric treatment regimen for cerebral toxoplasmosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.